STOCK TITAN

Morgan Stanley SEC Filings

MS NYSE

Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Morgan Stanley (NYSE: MS) SEC filings page on Stock Titan brings together the firm’s regulatory disclosures, including current reports on Form 8‑K and other registered securities information. These filings show how Morgan Stanley communicates material events such as quarterly and annual financial results, capital actions, regulatory capital developments and securities offerings.

Form 8‑K filings frequently cover the release of financial information for specific quarters and for the full year, with press releases and financial data supplements filed as exhibits. Other 8‑K reports describe changes in the firm’s Stress Capital Buffer under the Federal Reserve’s supervisory stress testing framework, providing context on Morgan Stanley’s U.S. Basel III Standardized Approach Common Equity Tier 1 capital requirements.

The filings also list the securities registered under Section 12(b) of the Securities Exchange Act of 1934, including common stock, multiple series of non‑cumulative preferred stock represented by depositary shares, and global medium‑term notes issued by Morgan Stanley or Morgan Stanley Finance LLC, with Morgan Stanley acting as guarantor for certain notes. Additional 8‑K filings describe the approval of forms of master notes for global medium‑term notes and related legal opinions and consents.

On Stock Titan, these SEC documents are updated as they are made available on EDGAR. AI‑powered summaries help explain the key points in lengthy filings, so users can quickly see what each 8‑K, 10‑K or 10‑Q addresses without reading every page. Investors can also use this page to monitor registered securities, preferred stock disclosures and other regulatory information related to Morgan Stanley.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
-
Rhea-AI Summary

Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is marketing Buffered Jump Securities with an Auto-Callable feature linked to the worst performer among the S&P 500 (SPX), Nasdaq-100 (NDX) and Russell 2000 (RTY) indexes. Each $1,000 security can be automatically redeemed on 5 Aug 2026 if all three indexes are at or above their initial levels; investors would then receive an early redemption payment of $1,130–$1,150, capping upside thereafter.

If the note is not called, investors participate in 150% of any positive performance of the worst-performing index at maturity on 3 Aug 2028. Downside is mitigated by a 20% buffer; losses begin only if the worst performer has declined by more than 20%, after which the payoff falls one-for-one, exposing investors to a maximum 80% loss.

The issuer’s estimated value is $964.80 (≈3.5% below issue price), reflecting fees and hedging costs. The notes pay no periodic interest, will not be listed, and expose holders to Morgan Stanley’s credit risk. Key risk factors include limited liquidity, valuation opacity, early-call uncertainty, and tax complexity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
Rhea-AI Summary

Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is marketing Buffered Jump Securities with an Auto-Callable feature linked to the worst performer among the S&P 500 (SPX), Nasdaq-100 (NDX) and Russell 2000 (RTY) indexes. Each $1,000 security can be automatically redeemed on 5 Aug 2026 if all three indexes are at or above their initial levels; investors would then receive an early redemption payment of $1,130–$1,150, capping upside thereafter.

If the note is not called, investors participate in 150% of any positive performance of the worst-performing index at maturity on 3 Aug 2028. Downside is mitigated by a 20% buffer; losses begin only if the worst performer has declined by more than 20%, after which the payoff falls one-for-one, exposing investors to a maximum 80% loss.

The issuer’s estimated value is $964.80 (≈3.5% below issue price), reflecting fees and hedging costs. The notes pay no periodic interest, will not be listed, and expose holders to Morgan Stanley’s credit risk. Key risk factors include limited liquidity, valuation opacity, early-call uncertainty, and tax complexity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
prospectus

FAQ

How many Morgan Stanley (MS) SEC filings are available on StockTitan?

StockTitan tracks 3425 SEC filings for Morgan Stanley (MS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Morgan Stanley (MS)?

The most recent SEC filing for Morgan Stanley (MS) was filed on June 30, 2025.